000 | 01194nam a22002417a 4500 | ||
---|---|---|---|
003 | OSt | ||
005 | 20241007121135.0 | ||
008 | 241007b xxu||||| |||| 00| 0 spa d | ||
040 |
_c00001 _aUnicoc _bspa _d00001 |
||
082 | _a615 W927p | ||
100 | _aWorld Health Organization | ||
245 |
_aPublic-Private Roles In The Pharmaceutical Sector _b: Implications for equitable access and rational drug use _c/ World Health Organization |
||
260 |
_aGeneva: _bWorld Health Organization |
||
300 | _a103 Paginas. | ||
440 | _aHealth economic and drug No 5 | ||
504 | _aReferences (p91-100) | ||
505 |
_tPublic and private roles in the pharmaceutical sector. -- _tPharmaceutical markets: structure and performance. -- _tEssential state responsibilities. -- _tThe public-private mix in drug markets: a global picture. -- _tMarket mechanisms in public drug supply. -- _tPromoting public health needs through the private sector. -- _tPharmaceutical production and public-private roles. -- _tCapacity-building and the process of change. -- _tManaging public-private roles. |
||
526 | _5Unicoc | ||
546 | _aInglés | ||
590 | _aJERB | ||
650 | 0 |
_91008 _aFarmacologĂa |
|
942 |
_2ddc _cLIBROS |
||
999 |
_c1160 _d1160 |